rss
twitter
info@bioethicsobservatory.org
default-logo
default-logo
  • SPECIAL REPORTS
  • NEWS
  • NEWSLETTERS
    • SITE CONTENTS
  • PUBLICATIONS
  • ABOUT US
BREAKING NEWS
Medical, legal, social and bioethical assessment of euthanasia. Part II. Bioethical Aspects
North America’s two cell therapy companies fined for medical fraud. Is it the tip of an iceberg?
Is the success of organ transplantation “Spanish model” due to the current law of organ donation presumed consent?
Debate on fraud in scientific papers continues. A complex and challenging issue for scientific journals
Rebuild trust between doctors-patients and healthcare institutions is claimed
Euthanasia, the other side of the coin. What did patients face after their decision to end their life?
In vivo cell reprogramming. A major step forward in regenerative medicine
Cooperation between Science and Faith proposed for the well-being of the planet
Single-cell sequencing tool opens up promising possibilities in life cycle and biomedical research
Same-sex parents produced in mammals. Mouse pups obtained from “exclusively” male or female pairs
Abortion’s effect on the mother’s health and risk of death. Pregnancy, miscarriage and induced termination of pregnancy

In vivo cell reprogramming. A major step forward in regenerative medicine

New possibilities for repairing organic lesions included aging are found in cell reprogramming in vivo in animal experimentation
Posted On 06 Feb 2019
By : Bioethics Observatory - Institute of Life Sciences UCV
Comment: 0

Animal Testing / BIOETHICS NEWS / Cell therapy / Embryonic Stem Cells / SPECIAL REPORTS / Stem Cells / Uncategorized

Cell reprogramming  is revolutionizing the biomedical world, not only because it can obtain cells of different tissues from pluripotent cells, but also because these cells can be genetically modified to be used for the treatment of serious illnesses or to better understand them, for the experimental assessment of drugs and also for the artificial production of organs. They can even be used to modify cell aging, extending that possibility to the rejuvenation of human beings, a necessary step for what has come to be called “enhancement” or improvement of the human body, a prologue to trans- and post-humanism, in my opinion, the most profound technological revolution in history.

These types of experiments originally used embryonic stem cells, from which all types of cells and tissues, and even living adult organisms, can be derived. However, these cells have the ethical drawback that human embryos must be destroyed in order to use them, as many of them are obtained from the inner cell mass of the blastocyst, an embryo of between 7 and 14 days (See related articles: Possible clinical usefulness of embryonic stem cells, Therapeutic use of human embryonic stem cells, Use of embryonic stem cells to treat severe eye diseases).

This difficulty was resolved in 2006 when Yamanaka’s group in Tokyo developed the possibility of reprogramming adult somatic cells to cells similar to embryonic ones, induced pluripotent stem cells, or iPS cells, which can be used as laboratory material to obtain pluripotent stem cells. Their use does not entail any ethical difficulty, because as mentioned, they are obtained from adult cells (see HERE).

Nevertheless, this technique presents methodological difficulties, most notably the production of alterations in the genome of the cells obtained, so their use in medicine still requires further extensive experiments.

Up to now, we have referred to the possibility of reprogramming cells in the laboratory, “in vitro”, but is there a possibility of doing so in vivo? If so, this would open the door to new therapeutic regimens, by being able to treat abnormalities of human organs in vivo, i.e. in the patient him- or herself, possibly using their own stem cells.

Treating abnormalities of organs in vivo was achieved in animal experimentation

What originally seems almost a utopia was first achieved in 2013 by a group of Spanish scientists working in the Spanish National Cancer Research Centre, led by Manuel Serrano, in an article published in Nature . According to Elena Vicario and Eric Vázquez-Ferrer, in the September issue of Investigación y Ciencia the same year, “the researchers created a type of mouse, which they called 4F, which were carriers of the four Yamanaka factors. Activation of these factors is controlled by a gene which, in turn, can be activated by administering doxycycline, which is given to the mice in their drinking water. The researchers showed that it was possible to trigger cell reprogramming in these rats by administering this drug”, but as Manuel Serrano says, in the title of the aforementioned study, teratomas (cancer cells) were produced in the cells generated. The authors therefore concluded their study by stating that “These discoveries could be relevant for future applications of reprogramming in regenerative medicine”, so, in our opinion, their clinical use in humans is still a long way off. Nevertheless, the first steps are already being taken in this direction.

Indeed, two interesting studies later described how cells can be reprogrammed in live mice with progeria (a disease that causes premature aging), confirming that partial cellular programming can be achieved using a short induction of the four Yamanaka factors, which, in addition to maintaining its effect on cell aging, did not lead to tumor formation. This is undoubtedly a major step forward in in vivo cellular reprogramming, which even opens the door to promising anti-aging strategies, although its application in humans is still some way off (see HERE https://www.investigacionyciencia.es/revistas/investigacion-y-ciencia/cruzar-la-frontera-cuntica-743/frenar-el-envejecimiento-mediante-la-reprogramacin-celular-16671).

However, Izpisua’s group has just had a breakthrough in the field of in vivo cell reprogramming, by showing the possibility of regenerating skin in animals with large skin lesions (see HERE https://www.nature.com/articles/s41586-018-0477-4). As it says in the aforementioned article, “Large cutaneous ulcers are, in severe cases, life threatening. As the global population ages, non-healing ulcers are becoming increasingly common. Treatment currently requires the transplantation of pre-existing epithelial components, such as skin grafts, or therapy using cultured cells. Here we develop alternative supplies of epidermal coverage for the treatment of these kinds of wounds. We generated expandable epithelial tissues using in vivo reprogramming of wound-resident mesenchymal cells. Transduction of four transcription factors that specify the skin-cell lineage enabled efficient and rapid de novo epithelialization from the surface of cutaneous ulcers in mice. Our findings may provide a new therapeutic avenue for treating skin wounds and could be extended to other disease situations in which tissue homeostasis and repair are impaired”.

How far these new possibilities for repairing organic lesions will go is yet to be determined, but that they constitute an open door to achieving these goals seems certain.

Bioethical approach

From a bioethical point of view, this line of research can avoid embryonic stem cells experiments with their corresponding ethical concerns that human embryos must be destroyed in order to use them.

Justo Aznar

Bioethics Observatory

 

Share on FacebookTweet about this on TwitterShare on StumbleUponEmail this to someoneDigg thisShare on RedditShare on LinkedInShare on Google+Pin on Pinterest
About the Author
Our website includes “Special Reports” and news, based on the latest biomedical and biotechnological research findings from the world’s top medical and scientific journals. A multidisciplinary editor staff gives a medical and personalistic bioethical assessment. It is also a dynamic means of communication with our readers to reflect on these issues.
    Previous Story

    Single-cell sequencing tool opens up promising possibilities in life cycle and biomedical research

    Next Story

    Euthanasia, the other side of the coin. What did patients face after their decision to end their life?

    Related Posts

    Cell therapy clinics fraude are cheating the more vulnerable patients. They don't need approbation of FDA which contravenes the most basic ethical norms
    0

    North America’s two cell therapy companies fined for medical fraud. Is it the tip of an iceberg?

    Posted On 14 Feb 2019
    , By Bioethics Observatory - Institute of Life Sciences UCV
    Mice produced form same sex parents prove the technical possibility of crossing the barriers of biiparental reproduction in mammals.
    0

    Same-sex parents produced in mammals. Mouse pups obtained from “exclusively” male or female pairs

    Posted On 04 Feb 2019
    , By Bioethics Observatory - Institute of Life Sciences UCV
    A
    0

    Cancer cell therapy, still experimental, beats terminal breast cancer woman with secondary cancers

    Posted On 22 Oct 2018
    , By Bioethics Observatory - Institute of Life Sciences UCV
    The cells obtained showed normal cardiac markers and electromechanical characteristics which indicate a great quality of the cardiomyocytes produced
    0

    Cardiac muscle cells, that drive the beating of the heart, developed from iPS cells

    Posted On 24 Jul 2018
    , By Bioethics Observatory - Institute of Life Sciences UCV

    Leave a Reply Cancel reply

    *
    *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    CATEGORIES

    • Abortion
    • Abortion Pill RU-486
    • Adult Stem Cells
    • AIDS. HIV. Other viral infections
    • Animal Testing
    • Artificial intelligence
    • Artificial life
    • Assisted reproduction and IVF
    • Assisted Suicide
    • Bioethics
    • BIOETHICS NEWS
    • biomedical research
    • Cell therapy
    • Cloning
    • Coma Patients
    • Death Penalty
    • Demography
    • Designer Babies
    • Ecology
    • Embryonic Stem Cells
    • Emergency Contraception
    • Ethics of Scientific Research
    • Euthanasia
    • Fertility
    • Gender Ideology
    • Gene Therapy
    • Genetics and Genomics
    • Homosexuality
    • Human Disability
    • Human embryos
    • Human Rights
    • Human-animal hybrid
    • Informed consent
    • Intrauterine Medicine
    • LATEST BRIEF NEWS
    • Marriage and Family
    • Medical Deontology
    • Mental heath
    • Neuroscience
    • NEWS
    • News Briefs
    • Organ donation
    • Organ Transplant
    • Origin of the universe and life
    • Palliative Care
    • Preimplantational genetic diagnosis
    • Regenerative Medicine
    • Regulation of human reproduction
    • Reports
    • RESOURCES
    • Science and Religion
    • Sexuality and STDs
    • SPECIAL REPORTS
    • Stem Cells
    • Suicide
    • Surrogate pregnancy
    • Synthetic Biology
    • Transhumanism
    • Transsexuality
    • Uncategorized
    • Videos

    NEWSLETTER

    VISIT OUR SPANISH SITE

    CONTACT FORM

    TAG CLOUDS

    Abortion Adult Stem Cells Adult Stem Cells: Cell reprogramming iPS cells Adult stem cells: Therapeutic and Experimental Use AIDS. HIV. Other viral infections Assisted reproduction: Ethical and Moral Assessment Assisted reproduction: Side Effects Assisted reproduction: Social Aspects Assisted reproduction: Surrogacy Assisted reproduction: surrogate motherhood Assisted reproduction: Use of gametes Assisted reproduction and IVF Bioethics Bioethics: General Aspects Bioethics: Legal aspects Demography Demography: Statistics Ethics of Scientific Research Euthanasia Euthanasia: By Country and Region Euthanasia: Legal Regulations Gender Ideology Gene Therapy Genetics and Genomics Genetics and Genomics: Gene edition and Crispr Genetics and Genomics: Germ line Homosexuality Human Disability Human Embryos Human Embryos: General Aspects Human Embryos: Therapeutic and Experimental Use Medical Deontology Organ Transplant Organ Transplant: Clinical Aspects Organ Transplant: Ethical Aspects Organ Transplant: Organ Donation Palliative Care Palliative Care: Ethical Aspects Palliative Care: Medical Aspects Regenerative Medicine Regenerative Medicine: Organ production Regulation of human reproduction Sexuality and STD Suicide Transsexuality

    CATEGORIES

    • Abortion
    • Abortion Pill RU-486
    • Adult Stem Cells
    • AIDS. HIV. Other viral infections
    • Animal Testing
    • Artificial intelligence
    • Artificial life
    • Assisted reproduction and IVF
    • Assisted Suicide
    • Bioethics
    • BIOETHICS NEWS
    • biomedical research
    • Cell therapy
    • Cloning
    • Coma Patients
    • Death Penalty
    • Demography
    • Designer Babies
    • Ecology
    • Embryonic Stem Cells
    • Emergency Contraception
    • Ethics of Scientific Research
    • Euthanasia
    • Fertility
    • Gender Ideology
    • Gene Therapy
    • Genetics and Genomics
    • Homosexuality
    • Human Disability
    • Human embryos
    • Human Rights
    • Human-animal hybrid
    • Informed consent
    • Intrauterine Medicine
    • LATEST BRIEF NEWS
    • Marriage and Family
    • Medical Deontology
    • Mental heath
    • Neuroscience
    • NEWS
    • News Briefs
    • Organ donation
    • Organ Transplant
    • Origin of the universe and life
    • Palliative Care
    • Preimplantational genetic diagnosis
    • Regenerative Medicine
    • Regulation of human reproduction
    • Reports
    • RESOURCES
    • Science and Religion
    • Sexuality and STDs
    • SPECIAL REPORTS
    • Stem Cells
    • Suicide
    • Surrogate pregnancy
    • Synthetic Biology
    • Transhumanism
    • Transsexuality
    • Uncategorized
    • Videos
    Copyright ©2016 Bioethical Observatory | Designed and created by Logo de 130 caracteres www.130caracteres.com
    Subscribe

    Subscribe to our newsletter:

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
    Privacy & Cookies Policy